KYMR
Kymera Therapeutics, Inc. · Healthcare
Director Bruce Booth sold $34.8M of Kymera Therapeutics, Inc.
Sold$34,812,909
$121.86Price
285,684Shares
−35%Stake
What KYMR did after the filing
- The stock from Fri, Jun 26 open, $114.00
- −4.8%
- S&P 500, same days
- +6.0%
Measured over 30 trading days, to the Aug 10 close.
Traded Thu, Jun 25. Filed Thu, Jun 25, 9:56 PM ET, after the close. Returns use the Jun 26 open and the Aug 10 close. Not investment advice.